Literature DB >> 11074015

Contribution of circulating renin to local synthesis of angiotensin peptides in the heart.

G Prescott1, D W Silversides, S M Chiu, T L Reudelhuber.   

Abstract

The activity of a local cardiac renin-angiotensin system (RAS) has long been suspected in the promotion of cardiac pathologies including hypertrophy, ischemia, and infarction. All of the components of the RAS cascade have been demonstrated to be synthesized within the heart with the possible exception of the first enzyme in the cascade, renin. In the current study, we provide direct evidence that circulating renin can contribute to cardiac-specific synthesis of angiotensin peptides. Furthermore, we demonstrate this effect is independent of blood pressure and that in animals of comparable blood pressure, elevated circulating renin significantly enhances cardiac fibrosis. These results may serve to explain some of the cardiac pathologies associated with the RAS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11074015     DOI: 10.1152/physiolgenomics.2000.4.1.67

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  5 in total

1.  Prolonged exposure of cardiac cells to renin plus angiotensinogen reduces intracellular renin in the failing heart. On the role of angiotensin II-AT1 complex internalization.

Authors:  Walmor C De Mello; Yamil Gerena
Journal:  Regul Pept       Date:  2009-03-20

2.  A novel mouse model of advanced diabetic kidney disease.

Authors:  Jean-Francois Thibodeau; Chet E Holterman; Dylan Burger; Naomi C Read; Timothy L Reudelhuber; Christopher R J Kennedy
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

3.  Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy.

Authors:  Alex A Gutsol; Paula Blanco; Taben M Hale; Jean-Francois Thibodeau; Chet E Holterman; Rania Nasrallah; Jose W N Correa; Sergey A Afanasiev; Rhian M Touyz; Chris R J Kennedy; Dylan Burger; Richard L Hébert; Kevin D Burns
Journal:  PLoS One       Date:  2022-02-17       Impact factor: 3.240

Review 4.  Evaluating the adverse outcome of subtypes of heart failure with preserved ejection fraction defined by machine learning: A systematic review focused on defining high risk phenogroups.

Authors:  Simon W Rabkin
Journal:  EXCLI J       Date:  2022-02-22       Impact factor: 4.068

5.  Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension.

Authors:  Rhéure Alves-Lopes; Augusto C Montezano; Karla B Neves; Adam Harvey; Francisco J Rios; Dominik S Skiba; Lauren B Arendse; Tomasz J Guzik; Delyth Graham; Marko Poglitsch; Edward Sturrock; Rhian M Touyz
Journal:  Hypertension       Date:  2021-07-26       Impact factor: 10.190

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.